Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 123

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 123
---
  
 of the share reserve under the Incentive Plan.                                                |

HVII Public Shareholders who do not redeem their HVII Class A Ordinary Shares may also experience dilution in connection with or after the Business Combination as a result of the PIPE Investment, if any, and the amount of any such dilution will depend on the final terms of the PIPE Investment.

| 77 |

The issuance of additional shares of New ONE Nuclear Common Stock (or other equity securities of equal or senior rank) including through the exercise of rights or options, could have the following effects for HVII Public Shareholders who elect not to redeem their shares:

| ● | your                                                               
 proportionate ownership interest in New ONE Nuclear will decrease; |

| ● | the                                                                                           
 relative voting strength of each previously outstanding share of New ONE Nuclear Common Stock 
 will be diminished; or                                                                        |

| ● | the                                                                 
 market price of shares of New ONE Nuclear Common Stock may decline. |

HVII or ONE Nuclear may waive one or more of the conditions to the Business Combination.

HVII may agree to waive, in whole or in part, some of the conditions to its obligations to complete the Business Combination, to the extent permitted by the HVII Charter and applicable laws. For example, it is a condition to HVII’s obligations to close the Business Combination that certain of ONE Nuclear’s representations and warranties are true and correct in all respects as of the closing date, except where the failure of such representations and warranties to be true and correct, taken as a whole, does not result in a material adverse effect. However, if the HVII Board determines that it is in the HVII Public Shareholders’ best interest to waive any such Company Material Adverse Effect (as defined in the Business Combination Agreement), then the HVII Board may elect to waive that condition and close the Business Combination. Additionally, pursuant to the terms of the Business Combination Agreement, as a closing condition (subject to certain exceptions), the shares of New ONE Nuclear Common Stock to be issued in connection with the Business Combination are to be approved for listing on Nasdaq, but there can be no assurance that such listing condition will be met. If such listing condition is not met, the Business Combination will not be consummated unless the listing condition is waived by the parties to the Business Combination Agreement. Following the Closing, the shares of New ONE Nuclear Common Stock are intended to be listed, subject to Nasdaq approval, under the proposed symbol “ONEN.” It is important for you to know that, at the